Growth Factor Regulation of Fracture Repair

FRACTURE REPAIR CAN BE considered as a biologically optimal process resulting in the restoration of injured skeletal tissue to a state of normal structure and function. Although the process leads to healing in the vast majority of cases, a small but significant proportion of fractures result in delayed union or persistent nonunion. Surgical interventions have been directed toward enhancing the fracture repair process, normalizing the rate of healing, and decreasing the likelihood of nonunion. During fracture repair, a number of growth factors, cytokines, and their cognate receptors are present at elevated levels in and around the fracture site. Many of these proteins are normally expressed in skeletal tissue, and others are released from associated inflammatory cells at the site of injury. The induction of these proteins is regulated both spatially and temporally, suggesting that they play an active role in promoting fracture repair. The following review will summarize the current literature on the roles of the major cytokines and growth factors involved in fracture repair. In addition, the signaling cascades induced by these molecules will be discussed. While many cytokine and growth factor signaling events have not been specifically examined in the context of fracture repair, a large body of literature on signal transduction has emanated from studies on these molecules in embryonic bone development. Given the conserved nature of these molecules and their signaling cascades from Drosophila to humans, and the similarities between the fracture repair process and embryonic bone development, it seems highly probable that these downstream signaling events are conserved in fracture repair. Fracture repair can be envisioned as involving five distinguishable processes, including the immediate response to injury, intramembranous bone formation, chondrogenesis, endochondral bone formation leading to the reestablishment of load bearing function, and bone remodeling. While these processes may be discussed individually, it should be recognized that the first four occur simultaneously during fracture repair and are likely to influence one another. Extensive remodeling of the newly formed bone follows these four concurrent processes and facilitates the reestablishment of the full biomechanical integrity of the bone. A number of investigators have commented on the similarities between the repair process and embryonic bone formation and indeed a number of specific events characteristic of embryonic bone formation are reiterated in fracture repair. This is especially evident as one begins to examine the specifics of local factors regulating fracture repair, specifically those involved in the events of endochondral bone formation. The immediate response to injury from the fracture trauma is the initiating event of the fracture repair process. Fracture trauma involves not only an interruption of skeletal integrity but also a disruption of the normal vascular structures and nutrient flow at the fracture site. This leads to reduce oxygen tension, disruption of the marrow architecture, and results in the infiltration of inflammatory cells, macrophages, and degranulating platelets during formation of a hematoma. While it is likely that the mechanical stresses, changes in oxygen tension, and loss of vascular nutrients at the fracture site may signal some aspects of the healing process, the dominant initiators of fracture repair are most likely the numerous cytokines and growth factors released into the fracture site. To date the majority of research on fracture repair has focused on the actions of a relatively limited number of cytokines including interleukin-1 (IL-1), interleukin-6 (IL-6), tumor necrosis factor alpha, and macrophage colony-stimulating factor as well as the local growth factors fibroblast growth factor (FGF), platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-b), and the bone morphogenetic proteins (BMPs)-2, -3, -4, and -7. It is interesting to note that the majority of the factors mentioned have well described roles in the formation and patterning of the embryonic skeleton or in the homeostatic

[1]  B. Melsen,et al.  Limited chondro‐osteogenesis by recombinant human transforming growth factor‐β1 in calvarial defects of adult baboons (papio ursinus) , 1996 .

[2]  M. Bolander,et al.  Acidic fibroblast growth factor (aFGF) injection stimulates cartilage enlargement and inhibits cartilage gene expression in rat fracture healing , 1990, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[3]  J. Massagué,et al.  The transforming growth factor-beta family. , 1990, Annual review of cell biology.

[4]  Mark E. Bolander,et al.  Regulation of Fracture Repair by Growth Factors , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[5]  Nuclear Fusion of Signaling Pathways , 1999, Science.

[6]  R. Ross,et al.  A significant part of macrophage-derived growth factor consists of at least two forms of PDGF , 1985, Cell.

[7]  D. Givol,et al.  Complexity of FGF receptors: genetic basis for structural diversity and functional specificity , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  Hiroshi Fukuda,et al.  Recombinant Human Basic Fibroblast Growth Factor Accelerates Fracture Healing by Enhancing Callus Remodeling in Experimental Dog Tibial Fracture , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  K. Miyazono,et al.  Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  J. Massagué Receptors for the TGF-beta family. , 1992, Cell.

[11]  A. Reddi,et al.  Platelet-derived growth factor inhibits bone regeneration induced by osteogenin, a bone morphogenetic protein, in rat craniotomy defects. , 1993, The Journal of clinical investigation.

[12]  J. Massagué Receptors for the TGF-β family , 1992, Cell.

[13]  Subburaman Mohan,et al.  Growth factors for bone growth and repair: IGF, TGFβ and BMP , 1996 .

[14]  大西 敏之 Distinct and overlapping patterns of localization of bone morphogenetic protein (BMP) family members and a BMP type II receptor during fracture healing in rats , 1999 .

[15]  V. Rosen,et al.  THE HEALING OF SEGMENTAL BONE DEFECTS, INDUCED BY RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN (rhBMP‐2): A RADIOGRAPHIC, HISTOLOGICAL, AND BIOMECHANICAL STUDY IN RATS , 1993 .

[16]  E. Amento,et al.  Rapid publication TGF‐β1 induces bone closure of skull defects , 1991 .

[17]  B. Mckibbin,et al.  The biology of fracture healing in long bones. , 1978, The Journal of bone and joint surgery. British volume.

[18]  S. Santavirta Can safe be safer? Hip arthroplasty by hypotensive epidural anesthesia. , 1996, Acta orthopaedica Scandinavica.

[19]  M. Meltzer,et al.  Tumor necrosis factor. , 1991, Journal of the American Academy of Dermatology.

[20]  J. Heckman,et al.  The use of bone morphogenetic protein in the treatment of non-union in a canine model. , 1991, The Journal of bone and joint surgery. American volume.

[21]  E. Wang,et al.  Healing segmental femoral defects in sheep using recombinant human bone morphogenetic protein. , 1993, Clinical orthopaedics and related research.

[22]  C. Heldin,et al.  Signal transduction via platelet-derived growth factor receptors. , 1998, Biochimica et biophysica acta.

[23]  E. Vuorio,et al.  In situ localization of collagen production by chondrocytes and osteoblasts in fracture callus. , 1989, The Journal of bone and joint surgery. American volume.

[24]  T A Einhorn,et al.  The cell and molecular biology of fracture healing. , 1998, Clinical orthopaedics and related research.

[25]  D. Kingsley,et al.  The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. , 1994, Genes & development.

[26]  A. Reddi,et al.  Initiation of bone regeneration in adult baboons by osteogenin, a bone morphogenetic protein. , 1992, Matrix.

[27]  G. Finerman,et al.  Repair of segmental defects of the tibia with cancellous bone grafts augmented with human bone morphogenetic protein. A preliminary report. , 1988, Clinical orthopaedics and related research.

[28]  H. Oxlund,et al.  Local injection of TGF-β increases the strength of tibial fractures in the rat , 1994 .

[29]  D. Baltimore,et al.  Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho. , 1992, Science.

[30]  C. Avnstorp,et al.  Interleukin‐1 , 1987 .

[31]  Jian-Sheng Wang,et al.  Basic fibroblast growth factor for stimulation of bone formation in osteoinductive and conductive implants , 1996 .

[32]  Y. Sugioka,et al.  Localization and Quantification of Proliferating Cells During Rat Fracture Repair: Detection of Proliferating Cell Nuclear Antigen by Immunohistochemistry , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  A. Liss The TGF-(3 family and its composite receptors , 1994 .

[34]  S. Cook,et al.  The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. , 1994, The Journal of bone and joint surgery. American volume.

[35]  R. Coutts,et al.  Instructional Course Lectures, The American Academy of Orthopaedic Surgeons - Growth Factors as Therapeutic Agents*† , 1996 .

[36]  H. Dockrell The Cytokine Handbook , 1993 .

[37]  D. E. Ashhurst,et al.  Exogenous fibroblast growth factors-1 and -2 do not accelerate fracture healing in the rabbit. , 1995, Acta orthopaedica Scandinavica.

[38]  T. Sakou Bone morphogenetic proteins: from basic studies to clinical approaches. , 1998, Bone.

[39]  D. E. Ashhurst,et al.  The effect of exogenous transforming growth factor-beta 2 on healing fractures in the rabbit. , 1995, Bone.

[40]  P. ten Dijke,et al.  Distinct and overlapping patterns of localization of bone morphogenetic protein (BMP) family members and a BMP type II receptor during fracture healing in rats. , 1998, Bone.

[41]  M Browne,et al.  Use of Bone Morphogenetic Protein-2 in the Rabbit Ulnar Nonunion Model , 1996, Clinical orthopaedics and related research.

[42]  G Osaka,et al.  Development of tricalcium phosphate/amylopectin paste combined with recombinant human transforming growth factor beta 1 as a bone defect filler. , 1997, Journal of biomedical materials research.

[43]  K. Takaoka,et al.  Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[44]  R. Coutts,et al.  Growth factors as therapeutic agents. , 1997, Instructional course lectures.

[45]  M. Jaye,et al.  Mitogenic Effects of Fibroblast Growth Factors in Cultured Fibroblastsa , 1991 .

[46]  M. Klagsbrun,et al.  Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose. , 1986, The Journal of biological chemistry.

[47]  E. Ogata,et al.  Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats. , 1994, Endocrinology.

[48]  Kjeld Søballe,et al.  Transforming growth factor-β enhances fracture healing in rabbit tibiae , 1993 .

[49]  K. Miyazono,et al.  Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. , 1999, Science.

[50]  O O Oni,et al.  Early histological and ultrastructural changes in medullary fracture callus. , 1992, The Journal of bone and joint surgery. American volume.

[51]  A. Hirschman,et al.  Neutral protein‐degrading enzymes in experimental fracture callus: A preliminary report , 1989, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[52]  E. Canalis,et al.  Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts. , 1998, The Journal of clinical investigation.

[53]  J. Poser,et al.  Novel formulation of fibroblast growth factor‐2 in a hyaluronan gel accelerates fracture healing in nonhuman primates , 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[54]  K. Tracey,et al.  Tumor necrosis factor , 1993 .

[55]  J. Poser,et al.  Potential Role of Fibroblast Growth Factor in Enhancement of Fracture Healing , 1998, Clinical orthopaedics and related research.

[56]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.

[57]  C. R. Howlett,et al.  Effect of platelet-derived growth factor on tibial osteotomies in rabbits. , 1994, Bone.

[58]  R. Derynck,et al.  Smads: transcriptional activators of TGF-beta responses. , 1998, Cell.

[59]  D. Davy,et al.  The effect of osteogenin (a bone morphogenetic protein) on the formation of bone in orthotopic segmental defects in rats. , 1994, The Journal of bone and joint surgery. American volume.

[60]  T A Einhorn,et al.  The expression of cytokine activity by fracture callus , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[61]  G. Finerman,et al.  Resistant nonunions and partial or complete segmental defects of long bones. Treatment with implants of a composite of human bone morphogenetic protein (BMP) and autolyzed, antigen-extracted, allogeneic (AAA) bone. , 1992, Clinical orthopaedics and related research.

[62]  Kohei Miyazono,et al.  TGF-β signalling from cell membrane to nucleus through SMAD proteins , 1997, Nature.

[63]  E. Canalis,et al.  Effects of basic fibroblast growth factor on bone formation in vitro. , 1988, The Journal of clinical investigation.

[64]  M. Urist,et al.  Bone morphogenetic protein augmentation grafting of resistant femoral nonunions. A preliminary report. , 1988, Clinical orthopaedics and related research.

[65]  Nobuyuki Itoh,et al.  Fibroblast growth factors , 2001, Genome Biology.

[66]  J. Darnell,et al.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.

[67]  A. Freemont,et al.  Platelet-derived growth factor expression in normally healing human fractures. , 1995, Bone.

[68]  M. Bolander,et al.  Transforming growth factor-beta in the regulation of fracture repair. , 1990, The Orthopedic clinics of North America.

[69]  R. Derynck,et al.  Transcriptional Activators of TGF-β Responses: Smads , 1998, Cell.

[70]  J. Massagué,et al.  The TGF-β family and its composite receptors , 1994 .

[71]  M. Jaye,et al.  Structural diversity and binding of FGF receptors. , 1991, Annals of the New York Academy of Sciences.

[72]  T. Yamamuro,et al.  Calcium‐dependent neutral proteinase (calpain) in fracture healing in rats , 1994, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[73]  A. Burstein,et al.  The healing of segmental bone defects induced by demineralized bone matrix. A radiographic and biomechanical study. , 1984, The Journal of bone and joint surgery. American volume.

[74]  K Nakamura,et al.  Stimulation of bone formation by intraosseous application of recombinant basic fibroblast growth factor in normal and ovariectomized rabbits , 1997, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[75]  S. Cook,et al.  Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. , 1994, Clinical orthopaedics and related research.

[76]  A. McMahon,et al.  Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. , 1998, Science.

[77]  M. Bostrom,et al.  Expression of bone morphogenetic proteins in fracture healing. , 1998, Clinical orthopaedics and related research.

[78]  M. Klagsbrun,et al.  Extracellular matrix‐resident basic fibroblast growth factor: Implication for the control of angiogenesis , 1991, Journal of cellular biochemistry.

[79]  J. Darnell,et al.  Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. , 1995, Annual review of biochemistry.

[80]  G. Wesolowski,et al.  Growth stimulation of rat calvaria osteoblastic cells by acidic fibroblast growth factor. , 1987, Endocrinology.

[81]  E. Canalis,et al.  Growth factors and cytokines in bone cell metabolism. , 1991, Annual review of medicine.

[82]  B. Hogan,et al.  Bone morphogenetic proteins: multifunctional regulators of vertebrate development. , 1996, Genes & development.

[83]  K. Miyazono,et al.  Sequential expression of bone morphogenetic protein, tumor necrosis factor, and their receptors in bone-forming reaction after mouse femoral marrow ablation. , 1998, Bone.

[84]  A. Hata,et al.  TGF-β signalling through the Smad pathway , 1997 .